China
US–China trade war : will there be a winner ?
The U.S. and China are hours away from a new round of tariffs on each other’s goods, with no improvement in relations between the two rivals in sight. Will there be a winner, or only two big losers ?
The U.S. and China are hours away from a new round of tariffs on each other’s goods, with no improvement in relations between the two rivals in sight.
In a significant escalation, $200 billion of Chinese products will be subject to increased tariffs from 12:00 p.m. Beijing time on Monday, on top of the $50 billion in goods already charged higher duties earlier in the year. The combined $250 billion in products facing levies is almost half the value of imports from China last year.
Meanwhile, $60 billion of goods from the U.S. will become subject to Chinese higher tariffs around the same time, adding to the $50 billion already levied. That’ll mean about 70 percent of the value of goods China bought from America in 2017 face tariffs.
There are three major explanations for why the United States began its recent trade war with China
United States wants to reduce its trade deficit
The first is that the United States wants to reduce its trade deficits. US President Donald Trump tweeted on 4 April 2018 that ‘[the United States has] a Trade Deficit of $500 Billion a year, with Intellectual Property Theft of another $300 Billion. We cannot let this continue!’. Many US commentators think that the gargantuan imbalance translates into an incremental increase in US indebtedness to China, which they consider to be a huge vulnerability for the United States.
The United States wants to slow China’s progress toward being a high-tech superpower
The second is that the United States wants to slow China’s progress toward being a high-tech superpower. The main sectors in China getting hit are machinery, electronics and IT technology. This is tantamount to the United States’ directly targeting Made in China 2025.
The final explanation is that ‘Trump favours highly transactional exchanges’ and wants an increased stock of bargaining chips. Trump may well have begun a trade war with China now so that he can relinquish it later in exchange for cooperation over perplexing political and security issues.
Whatever the cause, China has been bashed by the trade war. Over the last five months, the Shanghai Composite Index — a barometer of the Chinese stock market — has plummeted by approximately 18 per cent and the Chinese renminbi has depreciated nearly 8 per cent. Because China is still export dependent, the trade war will make Chinese export firms lose approximately US$22 billion and will cause unemployment, especially in China’s east coast.
China faces daunting domestic challenges
Even without the trade war, China faces daunting domestic challenges.
After years of work, China’s economic structural change is slowly progressing. China’s private consumption as percentage of GDP has been increasing since 2010, but it has not yet breached 40 per cent (compared to a US average of 68 per cent). China’s gross savings rate is more than 46 per cent of GNP against the United States’ 17.3 per cent.
Continued high national savings for a long time fully financed Chinese investment and sustained it at a very high level. Even today, China’s investment accounts for 44.4 per cent of GDP. This prolonged investment on a massive scale has created significant overcapacity in a range of sectors and has engendered much debt — part of which has become non-performing loans.
The trade war will only drive the renminbi to further depreciate
Amid China’s internal issues, the trade war will only drive the renminbi to further depreciate. In recent months, Beijing has taken a series of monetary and fiscal initiatives to boost lending and restructure debt.
These initiatives may ameliorate the situation in the short term, but solving the problems completely and successfully will take much longer than expected. If the trade war lingers on until the end of 2018 or even till 2019, market sell-off pressure on the renminbi will likely increase. In addition, US economic indicators look sublime and the almost-inevitable interest rate raise will facilitate further renminbi depreciation.
The worst case scenario would be a persistent trade war coupled with US interest rate increases. This would elicit very negative sentiment and might cause large-scale capital flight from China.
But can the United States achieve the objectives it seeks from the trade war?
The United States cannot drive down or stop trade deficits for the foreseeable future. Anyone who understands balance of payments accounting knows that the sum of the current account and the capital account must equal zero. The United States has very flexible and liquid capital markets with highly credible governance, which lures countries with trade surpluses to export a large part of their excess savings to the United States.
In 2017, US net financial inflows stood at more than US$375 billion, and the capital account surplus exceeded US$400 billion. Further, in today’s trade regime, the capital account drives the savings account. Unless the United States can flip around its capital account surplus, overall trade deficits will remain huge.
Similarly, the United States will struggle to blight China’s Made in China 2025 initiative.
Technology innovation and investment are being promoted by the Chinese government.
There are now 1775 Chinese venture capital firms. China is determined to narrow the income gap between itself and the advanced countries. So a trade war aiming to refrain China from technological enhancement will ‘only strengthen Chinese leaders’ resolve to boost innovation and achieve technological supremacy, as they realise that they can’t rely on others’, as Joseph Stiglitz notes.
Finally, if Trump plans on using a trade war as a bargaining chip, he should know that China will not likely compromise, at least in the short term. Popular anger and national sentiment may well surge about the trade war, which would leave the Chinese government with little choice but to stand firm. China could use ‘strong sales of US brands’ as its own bargaining chip, but if the trade war lasts for more months and China’s economy continues to worsen, the US bargaining chips might increase in potency. Yet still, China could hardly give in to any conditions that violate its national interests.
The trade war will accomplish neither country’s objectives.
China and the United States need to install an effective communications channel, dispatch high-echelon officials who deeply understand each other, come to negotiations, and as Harvard economist Dani Rodrik suggests, ‘do not impose on other countries constraints that you would not accept if faced with their circumstances’.
Yuhan Zhang is an economist and independent researcher.
Who will be the winner of the US–China trade war? | East Asia Forum
Business
Wegovy: The Popular Weight-Loss Drug Now Available in China
Novo Nordisk launched Wegovy in China after approval, competing with Eli Lilly’s upcoming weight-loss drug. The treatment, costing 1,400 yuan, targets obesity but has potential side effects and isn’t covered by healthcare.
Wegovy Launch in China
Novo Nordisk recently launched its weight-loss drug, Wegovy, in China after obtaining approval from local health authorities in June. The introduction of Wegovy is expected to increase competition with Eli Lilly, which has also received approval for its weight-loss treatment, although it has not yet been released in China’s significant pharmaceutical market.
Cost and Accessibility
In China, a set of four Wegovy injections will be priced at 1,400 yuan (approximately $194), significantly lower than the drug’s U.S. price. However, patients will need to pay the full amount out of pocket since Wegovy is not yet covered by the national healthcare insurance plan.
Benefits and Side Effects
Research indicates that Wegovy can help users lose over 10% of their body weight. The drug contains semaglutide, which assists with appetite control and satiety. While Wegovy has been gaining traction globally, it may cause side effects like nausea. Concerns have emerged about its misuse among individuals who are not obese, prompting medical professionals to remain vigilant.
Source : Popular weight-loss drug Wegovy goes on sale in China
China
China Implements New Measures to Increase Foreign Investment in A-Share Market
China’s 2024 updates to strategic investment rules simplify A-share market access for foreign investors by lowering shareholding thresholds, reducing lock-up periods, and increasing investment options, reflecting a commitment to greater market openness and participation in economic reform.
The 2024 updates to China’s strategic investment rules simplify entry for foreign investors in the A-share market by lowering shareholding thresholds, reducing lock-up periods, and expanding investment options, signaling a commitment to increased market openness and flexibility through these new measures.
China’s capital markets are undergoing a significant transformation as part of the nation’s ongoing commitment to economic reform and openness. The recent update to the Administrative Measures for Strategic Investment in Listed Companies by Foreign Investors (hereinafter, the “new measures”) reflects this commitment, targeting an increase in foreign investor participation in China’s A-share market. For nearly two decades, China’s “strategic investment” pathway provided foreign investors with access to shares in A-share listed companies, but strict requirements—such as high minimum investment thresholds and prolonged lock-up periods—made it accessible only to select large investors.
The new measures, effective December 2, 2024, relax many of these restrictions to attract a broader and more diverse range of foreign investors. Key changes include lowering the minimum shareholding threshold from 10 percent to 5 percent, reducing the asset requirements from US$100 million to US$50 million in assets, and shortening the lock-up period from three years to one. Additionally, foreign investors can now use equity from unlisted overseas companies as consideration, while new investment routes, like tender offers, enhance flexibility.
In 2005, China introduced the Strategic Investment Regime as part of its broader efforts to open up its financial markets to foreign capital while retaining a level of control over sensitive industries. This framework allowed qualified foreign investors to acquire strategic stakes in Chinese A-share listed companies, aiming to promote foreign participation in the domestic market.
However, the stringent requirements—such as high minimum investment thresholds and extended lock-up periods—restricted this pathway to a limited pool of large, multinational investors. The regime reflected China’s cautious approach at the time, seeking to balance openness with economic stability and control over critical sectors.
A decade later, in 2015, China implemented its first significant revisions to the Strategic Investment Regime. These amendments sought to make the investment process more accessible by easing certain restrictions, aiming to encourage foreign capital inflow as China continued its gradual integration into global markets.
While some requirements were relaxed, the fundamental limitations—such as high entry thresholds and complex approval processes—remained in place, meaning that access to China’s A-share market was still primarily confined to major institutional investors with substantial capital.
This article was first published by China Briefing , which is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia from offices across the world, including in in China, Hong Kong, Vietnam, Singapore, and India . Readers may write to info@dezshira.com for more support. |
Read the rest of the original article.
China
Less is More: Rethinking Indonesia’s Tariffs on China
Rising concerns over China’s industrial overcapacity have led countries to impose higher tariffs, including Indonesia’s planned 200% tariffs on Chinese goods, risking Indonesia’s competitiveness and economic security.
Tariffs Escalate Amid Concerns of Overcapacity
Concerns regarding China’s industrial overcapacity have prompted countries to increase tariffs on Chinese goods. Indonesia, following the U.S. example, plans to impose tariffs as high as 200 percent on various Chinese imports, including textiles and ceramics. This response aims to safeguard local jobs from the influx of inexpensive Chinese products.
Economic Impact of Tariffs
These tariffs are designed as safeguards and anti-dumping measures against potential job losses in Indonesia. However, the ongoing investigations have not definitively shown that China’s practices are the root cause of these issues. The political appeal of broad tariffs might lead to unintended consequences, such as reducing the overall competitiveness of Indonesian exports and risking retaliatory measures from affected countries.
Dependency on Chinese Goods
Indonesia heavily relies on Chinese manufacturing inputs, which constituted over 26 percent of its intermediary goods imports in 2021. With competitive pricing, these inputs have enhanced Indonesia’s export capabilities, particularly to markets like the U.S., where the trade surplus increased from $8.58 billion in 2019 to $11.96 billion in 2023. Reducing trade openness may ultimately undermine the Indonesian economy’s resilience against geopolitical challenges.